Spyre Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Spyre Therapeutics, Inc. (SYRE) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.090.190.030.020.150.070.07
Short-Term Investments0.510.150.020.080.060.000.00
Cash & Short-Term Investments0.600.340.060.090.150.070.07
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.000.010.000.000.000.00
Total Current Assets0.610.340.060.100.150.070.08
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.010.010.010.010.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.000.000.010.010.010.010.00
Total Assets0.610.340.070.110.160.080.08
Current Liabilities
Accounts Payable0.000.000.000.000.020.020.01
Accrued Liabilities0.030.010.010.010.010.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.030.000.000.000.000.000.00
Total Current Liabilities0.050.030.010.020.020.020.01
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.010.000.00
Other Non-Current Liabilities0.040.040.000.000.000.000.00
Total Non-Current Liabilities0.040.130.010.010.010.000.00
Total Liabilities0.090.160.020.030.020.020.01
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.97-0.76-0.43-0.34-0.28-0.20-0.12
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.330.760.480.430.420.260.18
Shares Outstanding0.060.040.000.000.000.000.00
Total Stockholders' Equity0.520.180.050.080.140.060.07
Total Liabilities & Equity0.610.340.070.110.160.080.08